?1 prior regimen of chemotherapy for State-of-the-art breast cancer and across the entire trial, former publicity to any FGFR inhibitor, major operation or radiotherapy inside of four months previous to initially dose of research therapy and using powerful inhibitors or inducers of CYP3A4 or CYP2D6. Any of the next cardiac conditions precluded pati